Apollo Hospitals Enterprise Limited has announced the completion of a significant acquisition by its subsidiary Imperial Hospital and Research Centre Limited. The healthcare giant disclosed that Imperial Hospital has acquired Belenus Champion Hospitals Private Limited for a total consideration of Rs 1,650 million, marking a strategic expansion in the Bangalore healthcare market.

Acquisition Details

The acquisition structure involves Imperial Hospital and Research Centre Limited, in which Apollo Hospitals holds a 90% equity stake, purchasing 6,48,468 equity shares of Belenus Champion Hospitals Private Limited. The transaction details are as follows:

The total acquisition cost of Rs 1,650 million includes the equity value and settlement of existing liabilities. Following this transaction, Belenus Champion Hospitals Private Limited has become a wholly owned subsidiary of Imperial Hospital and Research Centre Limited and a step-down subsidiary of Apollo Hospitals.

Hospital Expansion Plans

Belenus operates a 125-bed hospital facility located on Marathahalli Road, Bangalore, under the brand name "Belenus Champion Hospital." The company has outlined ambitious expansion plans for the acquired facility:

The hospital is currently undergoing upgrades and expansion, with the facility set to reopen as a fully upgraded 175-bed multi-speciality hospital. The overall investment, including the initial acquisition cost of Rs 1,650 million, will total Rs 3,000 million.

Financial Performance of Acquired Entity

Belenus Champion Hospitals Private Limited, incorporated on 8th December 2021, has demonstrated varying financial performance over the past three years:

The company's revenue from operations for the financial year ended March 31, 2025, was Rs 274.90 million. The acquisition aligns with Apollo Hospitals' strategy to expand its hospital operations and strengthen its healthcare presence across key markets.

Strategic Implications

The acquisition represents Apollo Hospitals' continued focus on expanding its healthcare network through strategic investments. The transaction does not fall within the ambit of related party transactions, and no promoter group companies have any interest in the acquired entity. The deal was completed through cash consideration and required no governmental or regulatory approvals.

This expansion into Bangalore's healthcare market through the upgraded facility positions Apollo Hospitals to serve a broader patient base in one of India's key metropolitan areas. The investment demonstrates the company's commitment to enhancing healthcare infrastructure and services across the country.

Apollo Hospitals Enterprise Ltd. has recorded a significant block trade on the National Stock Exchange (NSE), highlighting substantial institutional activity in the healthcare major's shares.

Block Trade Details

The transaction represents a considerable institutional movement in Apollo Hospitals Enterprise Ltd. shares, executed through the NSE's block trading mechanism.

Understanding Block Trades

Block trades are large-volume transactions typically executed by institutional investors, mutual funds, or other large stakeholders. These trades are conducted outside the regular market order book to prevent significant price movements that could occur with such substantial volumes. The execution of block trades often indicates strategic portfolio adjustments by institutional investors or changes in major shareholding patterns.

Market Implications

The substantial value of Rs. 55.83 crores for this block trade underscores the significant institutional interest in Apollo Hospitals Enterprise Ltd. shares. Such transactions are closely monitored by market participants as they can provide insights into institutional sentiment and potential shifts in major shareholding structures within the company.